GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 62 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,169,126 | -14.1% | 1,261,120 | -2.6% | 0.00% | 0.0% |
| Q2 2023 | $2,526,102 | +127674.5% | 1,295,437 | +82.1% | 0.00% | 0.0% |
| Q1 2023 | $1,977 | +651.7% | 711,218 | +831.8% | 0.00% | – |
| Q4 2022 | $263 | -100.0% | 76,331 | -74.0% | 0.00% | – |
| Q3 2022 | $754,000 | -71.5% | 293,459 | -73.1% | 0.00% | -100.0% |
| Q2 2022 | $2,641,000 | +6.4% | 1,091,467 | +81.1% | 0.00% | +100.0% |
| Q1 2022 | $2,482,000 | -1.2% | 602,544 | +119.0% | 0.00% | -50.0% |
| Q2 2021 | $2,512,000 | -59.3% | 275,123 | -57.9% | 0.00% | -50.0% |
| Q1 2021 | $6,166,000 | +1264.2% | 653,920 | +469.7% | 0.00% | – |
| Q4 2020 | $452,000 | +164.3% | 114,792 | +77.9% | 0.00% | – |
| Q3 2020 | $171,000 | -85.9% | 64,529 | -64.6% | 0.00% | -100.0% |
| Q2 2020 | $1,210,000 | +1086.3% | 182,218 | +1439.8% | 0.00% | – |
| Q3 2019 | $102,000 | -91.7% | 11,834 | -86.3% | 0.00% | -100.0% |
| Q3 2018 | $1,232,000 | – | 86,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |